Lupin, a Rs.5,700 crore pharma major, is setting up a new state-of-the-art formulation manufacturing facility at the Special Economic Zone MIHAN, Nagpur. The greenfield plant will take close to a year to being set up.
Nilesh Gupta, group president & executive director, said, “The strategic investment in the new formulation facility at MIHAN is not only in keeping with the consistent growth that Lupin has witnessed across key markets like the US but it would also ensure that our manufacturing capacities are attuned to future demand. Nagpur as a location has strategic proximity to key metros as well as international aviation routes. We are happy to be here at MIHAN and to be able to contribute to the development of the local economy.”
Currently, the company operates 11 world class manufacturing facilities spread across India and Japan. Almost all of Lupin's facilities have inspected by leading regulators like the US FDA, UK MHRA, WHO, Australian TGA and Japan's MHLW.